Angina Pectoris



Angina Pectoris




GENERAL CONSIDERATIONS


Angina pectoris results when oxygen supply and, occasionally, other nutrients, are inadequate for metabolic needs of heart muscle. Primary cause is atherosclerosis; also platelet aggregation, coronary artery spasm, nonvascular mechanisms (e.g., hypoglycemia), and increased metabolic need (e.g., hyperthyroidism). Primary lesion of atherosclerosis is atheromatous plaque blocking coronary arteries; symptomatic after major coronary artery is more than 50% blocked, transient platelet aggregation (Textbook, “Atherosclerosis”), and coronary artery spasm.





THERAPEUTIC CONSIDERATIONS


Angina pectoris is a serious condition requiring careful treatment and monitoring. Prescription medications may be necessary; condition controllable with help of natural measures. Significant blockage of coronary artery: IV EDTA chelation, angioplasty, or coronary artery bypass may be appropriate. Two primary therapeutic goals: improve energy metabolism within heart and improve blood supply to heart. Heart uses fats as major metabolic fuel; defects in fat metabolism in heart greatly increase risk of atherosclerosis, MI, and angina attacks. Impaired use of fatty acids by heart results in accumulation of fatty acids within heart muscle, causing extreme susceptibility to cellular damage and MI. Carnitine, pantetheine, and coenzyme Q10 (CoQ10) are essential to fat metabolism and extremely beneficial in angina; prevent accumulation of fatty acids within heart muscle by improving conversion of fatty acids into energy.



Coronary Angiogram, Artery Bypass Surgery, and Angioplasty


Angiogram (cardiac catheterization) is a radiographic procedure; dye is injected into coronary arteries to highlight blockages, subsequently treated by surgery. To date, no study has demonstrated a mortality benefit of percutaneous transluminal coronary angioplasty (PTCA) or cardiac revascularizations (also known as coronary artery bypass graft [CABG] operations) over nonsurgical interventions in patients with stable coronary artery disease.


Medicine, Angioplasty, or Surgery Study (MASS-II) showed no difference in cardiac death or acute MI among patients in CABG, PCTA, or medical treatment groups. But there was greater need for additional revascularization in patients who underwent PCTA. Medical treatment is a reasonable alternative for patients with multivessel CAD.



• Angiograms: landmark study of patients told they needed angiograms to determine degree of blockage and need for bypass surgery or angioplasty. Noninvasive tests (exercise stress test, echocardiogram, 24-hour Holter monitor) revealed that 80% did not need catheterization. These patients had an annual fatal MI rate over a 5-year period much lower than mortality rates for surgical procedures. Noninvasive testing to determine the functional state of the heart is far more important in determining indicated therapy than is dangerous search for blocked arteries. If heart is dysfunctional, then angiogram is indicated to ascertain need for surgery. Blockages found by angiogram are usually not relevant to risk of MI.


• Coronary Artery Surgery Study (CASS): patients with heart disease who had healthy hearts, but one, two, or all three major heart vessels blocked, did surprisingly well without surgery. Regardless of number or severity of blockages, each group had the same low annual death rate of 1%. Severity of blockage does not estimate reduction in blood flow; no correlation between blood flow and severity of blockage; angiogram did not provide clinically relevant information. Critical factor: how well left ventricle is working, not degree of blockage or number of arteries affected. Bypass only helpful when ejection fraction is <40%. (Greater than 50% is adequate for circulatory needs.) Studies: 61% of patients who underwent bypass surgery had nervous system disorders as a result; 2%-5% die during or soon after operation; 10% have MIs.


• Dietary and lifestyle changes: significantly reduce risk of MI and other causes of death from atherosclerosis (Textbook, “Atherosclerosis”). Nutritional supplements and botanical medicines improve heart function in even the most severe angina cases. IV EDTA chelation: controversial, but clinical research has proven its efficacy.


• When cardiac procedure is unavoidable, goal is to prevent damaging effects and restenosis: high-potency multiple vitamin-mineral, additional vitamin C (500 mg t.i.d.+) and CoQ10 (100 mg q.d. 2 weeks before surgery and for 3 months after); garlic and high dosages vitamin E (>200 IU) to be avoided before surgery because of inhibition of platelet aggregation. Vitamin C plummets by 70% 24 hours after bypass surgery and persists for 2 weeks. After surgery, vitamin E and carotene levels do not change significantly—fat-soluble and retained longer; vitamin C depletion may deteriorate wound repair and defenses against free radicals and infection; CoQ10 can prevent oxidative damage during reperfusion. (Return of blood after bypass surgery induces oxidative damage to vascular endothelium and myocardium, increasing risk for subsequent coronary artery disease.) CoQ10 (150 mg q.d. for 7 days before surgery) prevents reperfusion injury and lowers incidence of ventricular arrhythmias during recovery period. Mixture of purified bovine aortic glycosaminoglycans (dermatan sulfate, heparin sulfate, hyaluronic acid, chondroitin sulfate) (100 mg q.d.) helps prevent reperfusion injury and restore structural integrity of endothelium.

Stay updated, free articles. Join our Telegram channel

Apr 3, 2017 | Posted by in GENERAL & FAMILY MEDICINE | Comments Off on Angina Pectoris

Full access? Get Clinical Tree

Get Clinical Tree app for offline access